Item 1

Call to Order and Welcome – Natalie Vanek, M.D., Committee Chair

Item 2

Logistical Announcement and Roll Call – Sallie Allen, Advisory Committee Coordination Office, HHSC

Item 3

Consideration of July 30, 2021, Meeting Minutes (Vote Required) – Sallie Allen, Advisory Committee Coordination Office, HHSC

Item 4

Department of State Health Services updates – Imelda Garcia, MPH Associate Commissioner of Laboratory and Infectious Disease Services (LIDS) a. Staffing Updates b. HIV Budget report c. September 29, 2021 Partnership meeting summary update

Item 5

THMP Update - Rachel Sanor, THMP Manager a. MAC appointment process b. THMP - Projections and Demographic information c. THMP backlog d. Spend down suspension e. 90-day supply analysis

Item 6

Pharmacy Annual Inventory Update & Report – Joshua Hutchison, Pharmacy Director

Item 8

Subcommittee reports a. Governance/Data – Nancy Miertschin b. Eligibility – Frank Rosas c. Formulary Sub-committee – Natalie Vanek, M.D. Impact of suspended medications Recommendation to approve pediatric medications Raltegravir 25mg (new dosage) Tivicay (new dosage)

Item 9 (Part 1 of 2)

Committee to vote on addition of Raltegravir 25 mg and Tivicay PD to THMP formulary (Vote Required)

Item 10

Public Comment – Sallie Allen, Advisory Committee Coordination Office, HHSC

Item 9 (Part 2 of 2)

Committee to vote on addition of Raltegravir 25 mg and Tivicay PD to THMP formulary (Vote Required)

Items 11 & 12

11. Action items and agenda topics for next scheduled meeting: January 22, 2022– Natalie Vanek, M.D., Committee Chair 12. Adjourn – Natalie Vanek, M.D., Committee Chair